# SESQUIENT
> **NDA210864** · New Drug Application · Sponsor: LUPIN · Approved 2020-11-05
## Drug
- **FDA Application Number:** NDA210864
- **Application type:** New Drug Application
- **Brand name:** SESQUIENT
- **Generic name:** Fosphenytoin Sodium
- **Active ingredients:** FOSPHENYTOIN SODIUM
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** LUPIN
- **First approval:** 2020-11-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210864)
---
*MORVS · CC0 1.0*